These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10920987)

  • 21. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas.
    Galoin S; al Saati T; Schlaifer D; Huynh A; Attal M; Delsol G
    Br J Haematol; 1996 Sep; 94(4):676-84. PubMed ID: 8826892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
    Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
    Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of bcl-2/IgH rearrangements by quantitative-competitive PCR and capillary electrophoresis.
    Telatar M; Grody WW; Emmanouilides C
    Mol Diagn; 2001 Sep; 6(3):161-8. PubMed ID: 11571709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients.
    Radojkovic M; Ristic S; Colovic M; Cemerikic-Martinovic V; Radojkovic D; Krtolica K
    Neoplasma; 2008; 55(5):421-7. PubMed ID: 18665753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of bcl-2/IgH gene rearrangement in diffuse large B cell lymphoma by hemi-nested PCR].
    Jiang HY; Zhang SQ; Han XQ; Song LY; Zhu MG; Zhao T
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):589-92. PubMed ID: 16532966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases.
    Thériault C; Galoin S; Valmary S; Selves J; Lamant L; Roda D; Rigal-Huguet F; Brousset P; Delsol G; Al Saati T
    Mod Pathol; 2000 Dec; 13(12):1269-79. PubMed ID: 11144922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
    Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
    Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of minimal residual disease in childhood hematological malignancies and its clinical significance].
    Tang S; Lu S; Zhang X; Ran C; Huang D; Wei X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):27-9. PubMed ID: 11876957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR.
    Batstone PJ; Goodlad JR
    J Clin Pathol; 2005 Jan; 58(1):81-2. PubMed ID: 15623489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contamination with minimal residual disease in autologous peripheral stem cell collected from Non-Hodgkin's lymphoma patients treated with high-dose therapy].
    Zhou A; Shi Y; Feng F; Lu S; He X; Han X
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):467-70. PubMed ID: 12485501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular analysis of telomere length in follicular lymphomas. Its participation in tumor progression].
    Cottliar AS; Noriega MF; Narbaitz M; Slavutsky IR
    Medicina (B Aires); 2005; 65(2):143-6. PubMed ID: 16075809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.
    Summers KE; Goff LK; Wilson AG; Gupta RK; Lister TA; Fitzgibbon J
    J Clin Oncol; 2001 Jan; 19(2):420-4. PubMed ID: 11208834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT.
    Tzankov A; Hittmair A; Müller-Hermelink HK; Rüdiger T; Dirnhofer S
    Virchows Arch; 2002 Dec; 441(6):614-7. PubMed ID: 12461620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.